Treatment group | | | | | |
1/F/55 | Systemic symptoms, skin ulcers, sinusitis, alveolar opacities, ILD, myocardial infarct | AP | 1 | 30 | 4 | + |
2/M/69 | Systemic symptoms, skin vasculitis, sinusitis, alveolar opacities, ILD, proteinuria, TT arthritis | AP | 1 | 28 | 4 | + |
3/M/44 | Systemic symptoms, palpable purpura, nasal polyposis, pleurisy, myocarditis | MM | 1 | 24 | 3 | + |
4/F/53 | Skin ulcers, retinal haemorrhage, sinusitis, alveolar opacities, proteinuria | AP | 1 | 29 | 2 | – |
5/F/57 | Systemic symptoms, alveolar opacities, pleurisy, pericarditis, myocarditis | AP | 1 | 26 | 3 | – |
6/F/56 | Sinusitis, alveolar opacities | AP | 0 | 15 | 3 | – |
7/F/69 | Sinusitis, alveolar opacities, TT arthritis | MM, diplopia | 0 | 16 | 3 | – |
8/F/43 | Systemic symptoms, nasal polyposis, alveolar opacities, arthritis | MN | 0 | 15 | 2 | + |
9/F/33 | Skin ulcers, sinusitis, alveolar opacities | MM | 0 | 19 | 1 | – |
Control group | | | | | |
10/F/47 | Systemic symptoms, sinusitis, myocardial infarct, renal impairment | MM, stroke | 2 | 31 | 4 | – |
11/M/61 | Skin ulcers, sinusitis, alveolar opacities, proteinuria | MM | 1 | 23 | 4 | – |
12/M/28 | Sinusitis, alveolar opacities, intestinal vasculitis | MN | 1 | 15 | 3 | + |
13/F/66 | Systemic symptoms, sinusitis, pleurisy, pericarditis, intestinal vasculitis | MM | 1 | 25 | 2 | – |
14/M/29 | Systemic symptoms, nasal polyposis | MM, diplopia | 0 | 13 | 2 | + |
15/F/59 | Sinusitis, alveolar opacities | MM | 0 | 15 | 3 | + |
16/F/46 | Systemic symptoms, sinusitis, pleurisy, pericarditis | MM | 0 | 20 | 3 | + |
17/M/48 | Sinusitis, alveolar opacities | AP | 0 | 15 | 1 | – |
18/F/25 | Systemic symptoms, skin ulcers, alveolar opacities, pleurisy, pericarditis | * | 0 | 18 | 2 | + |